These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 16461312)
1. The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myeloma. Kaiser M; Zavrski I; Sterz J; Jakob C; Fleissner C; Kloetzel PM; Sezer O; Heider U Haematologica; 2006 Feb; 91(2):248-51. PubMed ID: 16461312 [TBL] [Abstract][Full Text] [Related]
2. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor. Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388 [TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor valproic acid inhibits proliferation and induces apoptosis in KM3 cells via downregulating VEGF receptor. Dong XF; Song Q; Li LZ; Zhao CL; Wang LQ Neuro Endocrinol Lett; 2007 Dec; 28(6):775-80. PubMed ID: 18063935 [TBL] [Abstract][Full Text] [Related]
4. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo. Shabbeer S; Kortenhorst MS; Kachhap S; Galloway N; Rodriguez R; Carducci MA Prostate; 2007 Jul; 67(10):1099-110. PubMed ID: 17477369 [TBL] [Abstract][Full Text] [Related]
5. Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis. Takai N; Kawamata N; Gui D; Said JW; Miyakawa I; Koeffler HP Cancer; 2004 Dec; 101(12):2760-70. PubMed ID: 15536623 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells. Wu Y; Guo SW Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):198-203. PubMed ID: 17376583 [TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells. Aouali N; Palissot V; El-Khoury V; Moussay E; Janji B; Pierson S; Brons NH; Kellner L; Bosseler M; Van Moer K; Berchem G Br J Haematol; 2009 Dec; 147(5):662-71. PubMed ID: 19793255 [TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma. Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270 [TBL] [Abstract][Full Text] [Related]
9. The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells. Mandl-Weber S; Meinel FG; Jankowsky R; Oduncu F; Schmidmaier R; Baumann P Br J Haematol; 2010 May; 149(4):518-28. PubMed ID: 20201941 [TBL] [Abstract][Full Text] [Related]
10. Valproic acid induces non-apoptotic cell death mechanisms in multiple myeloma cell lines. Schwartz C; Palissot V; Aouali N; Wack S; Brons NH; Leners B; Bosseler M; Berchem G Int J Oncol; 2007 Mar; 30(3):573-82. PubMed ID: 17273758 [TBL] [Abstract][Full Text] [Related]
11. Chronic administration of valproic acid inhibits PC3 cell growth by suppressing tumor angiogenesis in vivo. Gao D; Xia Q; Lv J; Zhang H Int J Urol; 2007 Sep; 14(9):838-45. PubMed ID: 17760752 [TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of valproic acid on cell cycle of Kasumi-1 cell line and its mechanism]. Zhao L; Zhang ZH; Zhu CM Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):802-5. PubMed ID: 19176032 [TBL] [Abstract][Full Text] [Related]
13. [Effects of sodium valproate on proliferation and apoptosis of human myelodysplastic syndromes cell line MUTZ-1]. Chen BA; Zhao HH; Gao C; Shao ZY; Xia GH; Dohner K Ai Zheng; 2007 Dec; 26(12):1323-9. PubMed ID: 18076794 [TBL] [Abstract][Full Text] [Related]
14. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells. Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692 [TBL] [Abstract][Full Text] [Related]
15. Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells. Fortunati N; Bertino S; Costantino L; Bosco O; Vercellinatto I; Catalano MG; Boccuzzi G Cancer Lett; 2008 Feb; 259(2):156-64. PubMed ID: 18006146 [TBL] [Abstract][Full Text] [Related]
16. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons. Kanai H; Sawa A; Chen RW; Leeds P; Chuang DM Pharmacogenomics J; 2004; 4(5):336-44. PubMed ID: 15289798 [TBL] [Abstract][Full Text] [Related]
17. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells. Ahn MY; Jung JH; Na YJ; Kim HS Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664 [TBL] [Abstract][Full Text] [Related]